Post Categories
When NSAAs Enter the Mix, Protein Therapeutics May Thrive
November 15, 2021
Protein therapeutics may soon represent a $200 billion market despite a few inherent limitations. The processes for manufacturing therapeutic proteins are not very efficient…
Can Gene Therapy Cure Sickle Cell Disease?
November 8, 2021
Despite being one of the world’s most common inherited blood disorders, sickle cell disease has few treatment options, even with the approval of three…
The Flu Shot and COVID: Will the Delta Variant Play a Role?
November 3, 2021
Cold and flu season is nearly here, with flu activity typically peaking between the months of December and February. But according to a recent…
New Hope for Ultra-Rare Childhood Disease
November 1, 2021
The recent release of findings from a small Phase 1 clinical trial not only gives hope to families affected by an ultra-rare childhood disease,…
CRISPR and the Continuing Quest for CAR-T Safety and Durability
October 27, 2021
CAR-T is an immunotherapy that is currently used to treat blood cancers and is in clinical trials to treat other cancers as well. This…
mRNA: Great Expectations vs. Limited Applications
October 18, 2021
While research on potential therapeutic applications of mRNA has been underway for more than a decade, the success of the Pfizer and Moderna COVID-19…
Will You Need a COVID-19 Vaccine Booster Shot?
October 13, 2021
On September 22, 2021, the U.S. Food and Drug Administration (FDA) approved a single booster dose of the Pfizer-BioNTech COVID-19 vaccine for specific communities….
When COVID-19 Vaccine Supply Doesn’t Meet the Need, Innovations Emerge
October 11, 2021
It is hard to believe that within one year of the declaration of the pandemic, as many as eleven COVID-19 vaccines received emergency authorized…
COVID-19 Symptoms in the Vaccinated vs. Unvaccinated
October 6, 2021
Earlier this month, the United States reached a crucial milestone: Per the Centers for Disease Control and Prevention (CDC) website, 55 percent of the…
How SARS-CoV-2 Spreads Infection So Efficiently | Part 3 – Invasion of the Variants
October 4, 2021
In the first two blogs of this three-part series on how SARS-CoV-2 spreads, QPS has covered how the SARS-CoV-2 spike protein can attach to…
Move Over AAV – Anelloviruses May Be Key to NextGen Gene Therapy
September 27, 2021
Biotech start-up Ring Therapeutics, founded by Flagship Pioneering in 2017, hopes to transform gene therapy by using a new class of vector — anelloviruses…
How SARS-CoV-2 Spreads Infection so Efficiently | Part 2 – Hijacking Host Cells
September 20, 2021
Like most viruses, SARS-CoV-2 infects its hosts by entering and “hijacking” the operations of a host cell. A significant amount of the research on…
Gene Therapy for Parkinson’s Disease
October 4, 2023
Parkinson’s disease is a progressive neurodegenerative disorder with no known cure. Current treatment options are limited, aiming to alleviate some symptoms through a combination…
“Truly Stunning” Research Genetically Engineers Virgin Birth in Fruit Flies
October 2, 2023
For the first time, scientists have genetically engineered fruit flies to undergo parthenogenesis, also known as virgin birth or asexual reproduction. The research, published…
What Is a Vector in Gene Therapy?
September 27, 2023
Gene therapy continues to emerge as a promising approach in the treatment and prevention of a wide range of disorders and diseases. Central to…
Examining the Expanding Landscape of Weight Loss Injectables
September 25, 2023
Recent headlines have been abuzz with the groundbreaking weight loss results achieved with the injectable drug semaglutide, demonstrating the potential for people with obesity…
Oligonucleotide Anti-Drug Antibodies (ADAs)
September 22, 2023
What is it? An anti-drug antibody, ADA, is an antibody that binds to the therapeutic drug. They are formed as an immune response when…
How Are Viruses Used in Gene Therapy?
September 20, 2023
Gene therapy has revolutionized the field of medical research by offering potential treatments for genetic disorders and diseases previously considered untreatable or incurable. A…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
